A clinical trial to study the effects of two drugs, Eladi churna and yastimadhu churna in patients with Amlapitta.
- Conditions
- Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
- Registration Number
- CTRI/2021/05/033554
- Lead Sponsor
- Gurukul Campus UAU haridwar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients having classical symptoms of Amlapitta.
Patients of either sex.
Chronicity upto 5 years.
patients between the age group 16-60 years.
Patients below 16 years and above 60 years.
Chronicity more than 5 years.
Patients having organic disease like gastric ulcer, duodenal ulcer.
Patients suffering from Amlapitta with any chronic disease like-Hiatus Hernia; Asthma, Tuberculosis, Malignancies, Liver Cirrhosis and Chronic Renal Failure, Diabetes etc. exclude from the study.
Any other systemic disorder other than Amlapitta.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in subjective parameters like-â?¢Hruddkanthadaha â?? Burning in chest and throat <br/ ><br>â?¢Tiktamlodgara â??Acid eructation <br/ ><br>â?¢Avipaka â??Indigesion <br/ ><br>â?¢Aruchiâ?? Anorexia <br/ ><br>â?¢Utkleshâ?? Nausea <br/ ><br>â?¢Gauravâ??Heaviness in whole body <br/ ><br>â?¢Shirashoolâ?? Headache <br/ ><br>â?¢Hritshoolâ??chest pain <br/ ><br>Timepoint: For subjective parameters at-1st,15th,30th,45th days
- Secondary Outcome Measures
Name Time Method Relief in objective parameters like <br/ ><br>â?¢Hb%,TLC,DLC,ESR <br/ ><br>â?¢Blood sugar: RBS <br/ ><br>â?¢Fractional Meal Test <br/ ><br>Timepoint: For objective parameters- <br/ ><br>1 and 45 days